GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Common Stock

Aptose Biosciences (TSX:APS) Common Stock : C$612.69 Mil (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Common Stock?

Aptose Biosciences's quarterly common stock increased from Mar. 2024 (C$609.78 Mil) to Jun. 2024 (C$619.87 Mil) but then declined from Jun. 2024 (C$619.87 Mil) to Sep. 2024 (C$612.69 Mil).

Aptose Biosciences's annual common stock increased from Dec. 2021 (C$559.85 Mil) to Dec. 2022 (C$594.37 Mil) and increased from Dec. 2022 (C$594.37 Mil) to Dec. 2023 (C$596.75 Mil).


Aptose Biosciences Common Stock Historical Data

The historical data trend for Aptose Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Common Stock Chart

Aptose Biosciences Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 481.31 550.18 559.85 594.37 596.75

Aptose Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 600.69 596.75 609.78 619.87 612.69

Aptose Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Aptose Biosciences Business Description

Traded in Other Exchanges
Address
251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Executives
Bernd Robert Seizinger Director
William Glenn Rice Director, Senior Officer
Erich Platzer Director
Rafael Bejar Senior Officer
Warren Whitehead Director
Gregory Kwok Lee Chow Senior Officer
Jotin Marango Senior Officer

Aptose Biosciences Headlines

No Headlines